Bal Pharma Ltd.
BSE: 524824 | Sector: Health care |
NSE: BALPHARMA | ISIN Code: INE083D01012 |
BSE 00:00 | 16 Apr | 62.40 |
0.15 (0.24%) |
OPEN
63.10 |
HIGH
64.00 |
LOW
61.00 |
NSE 00:00 | 16 Apr | 62.55 |
-0.10 (-0.16%) |
OPEN
63.50 |
HIGH
64.25 |
LOW
62.15 |
OPEN | 63.10 |
PREVIOUS CLOSE | 62.25 |
VOLUME | 3174 |
52-Week high | 73.00 |
52-Week low | 33.50 |
P/E | 160.00 |
Mkt Cap.(Rs cr) | 92 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
- Financial Overview
- Balance Sheet
- Profit & Loss
- Cash Flow
- Ratios
- Quarterly
- Half Yearly
- Nine Monthly
- Yearly
Filter:
Bal Pharma Ltd. (BALPHARMA) - Nine Monthly Result
Particulars (![]() |
Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 |
Net Sales/Income From Operations | 179.02 | 136.90 | 166.87 | 151.92 | 168.63 |
Other Income | 1.52 | 1.99 | 1.89 | 1.89 | 2.18 |
Total Income | 180.54 | 138.89 | 168.76 | 153.81 | 170.81 |
Total Expenditure | 159.66 | 131.44 | 153.23 | 136.69 | 153.61 |
Operating Profit | 20.88 | 7.45 | 15.53 | 17.12 | 17.20 |
Interest | 8.84 | 9.41 | 9.06 | 6.59 | 6.15 |
Gross Profit | 12.05 | -1.96 | 6.48 | 10.53 | 11.04 |
Depreciation | 4.93 | 4.00 | 3.75 | 4.77 | 4.22 |
PBT | 7.12 | -5.95 | 2.73 | 5.77 | 6.83 |
Tax | 2.40 | -0.57 | -0.25 | 1.30 | 1.87 |
Net Profit/(Loss) | 4.72 | -5.38 | 2.98 | 4.47 | 4.96 |
Minority Interest After NP | - | - | - | - | - |
Net Profit after Minority Interest | - | - | - | - | - |
Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Profit After Exceptional Items | 4.72 | -5.38 | 2.98 | 4.47 | 4.96 |
Equity Share Capital | 14.17 | 14.17 | 14.17 | 14.17 | 14.17 |
Reserves Excluding Revaluation Reserves | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EPS | |||||
Basic EPS | 3.33 | -3.80 | 2.10 | 3.15 | 3.37 |
Public Share Holding | |||||
No Of Shares (Crores) | 0 | 0 | 0 | 0 | 0.79 |
Share Holding (%) | 0.00 | 0.00 | 0.00 | 0.00 | 55.65 |
Promoters and Promoter Group Shareholding | |||||
a) Pledged/Encumbered | |||||
- Number of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
- Per. of Shares (as a % of the total sh. of prom. and promoter group) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
- Per. of Shares (as a % of the total Share Cap. of the company) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
b) Non-encumbered | |||||
- Number of Shares (Crores) | 0 | 0 | 0 | 0 | 0.63 |
- Per. of shares (as a % of the total sh. of prom. and promoter group) | 0.00 | 0.00 | 0.00 | 0.00 | 100.00 |
- Per. of shares (as a % of the total Share Cap. of the company) | 0.00 | 0.00 | 0.00 | 0.00 | 44.35 |
Note : | PBT include deferred tax and fringe benefit tax Net profit figures include extra-ordinary items income/expenditure. |
Quick Links for Bal Pharma:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices